Today on EDGAR Catalyst Radar Hidden Gems
PubCo Insight › Tickers › OCGN

$OCGNNASDAQ NMS - GLOBAL MARKET

Ocugen, Inc.
Biotechnology
Market Cap
$433.3M
Exchange
NASDAQ NMS - GLOBAL MARKET
Filings (365d)
32
News (14d)
2
CIK
0001372299
Website
Company site ↗
SEC Filing Timeline
8-KJun 03, 2026
Executive officer change · Items 5.02
8-KMay 14, 2026
Executive officer change · Items 5.02,8.01
8-KMay 14, 2026
Unregistered share issuance · Items 2.03,3.02,7.01,9.01
10-QMay 08, 2026
Quarterly report
8-KMay 07, 2026
Unregistered share issuance · Items 1.01,1.02,2.02,2.03,3.02,9.01
8-KMay 05, 2026
Earnings release · Items 2.02,8.01,9.01
8-KMay 04, 2026
Earnings release · Items 2.02,7.01,8.01,9.01
DEFA14AApr 28, 2026
Additional proxy
DEF 14AApr 28, 2026
Proxy statement
8-KMar 27, 2026
Reg FD disclosure · Items 7.01,9.01
8-KMar 24, 2026
Reg FD disclosure · Items 7.01,9.01
8-KMar 20, 2026
Other material event · Items 8.01
10-KMar 04, 2026
Annual report
8-KMar 04, 2026
Other material event · Items 8.01,9.01
8-KMar 04, 2026
Earnings release · Items 2.02,9.01
Recent News (Finnhub)
Canaccord Genuity Maintains Buy on Ocugen, Lowers Price Target to $11
Benzinga · May 27
Wall Street Lunch: BP Slips After Ousting Chairman Albert Manifold Over Governance Concerns
SeekingAlpha · May 26
Source-linked from SEC EDGAR + Finnhub aggregated news.
Not investment advice. Always verify on SEC.gov directly.